- The drug is not needed in the market. It offers no benefit in terms of efficacy and patients do not want to take medication 4 months before they need it for a seasonal allergy
- Terrible managed care and prior-authorizations are required. Physicians do not want to do this or deal with a specialty pharmacy
- 5 year long tern study but they only publish 3 year? Why?
- They did mot get the indication for 5-9 years old. Why? They are vague to answer
- Physicians make their money on a quick 3 second shot. Why would they go through the hassle.
- This is for primary care use not specialist and even that they don't want to be bothered
- Why pay $300 a month for 6-9 months when you can buy Zyrtec for $30 a month and take it when needed
- The drug makes no money and they will realize by February that nothing is coming in and will start cutting sales reps. They can not afford to keep everyone on for another with hopes that next year they can generate revenue. This is not be profitable.
- They are more concerned with you having a photo on your email, everyone signing their email the same, entering the time on your sales calls and idiotic tasks instead of real sales issues.
- They micromanage your spending right down to the $1 receipt
- Marketing as no clue what they are doing. They don't have the experience. They make up 40 sales pieces that are useless but do not send you the few pieces that are useful. What a disgraceful way to waste money and job justification.
- Leadership does not really know what each department is doing.
- Benefits are awful!!! No 401k for 6 month and even then it's bad. In 6 months they know people will be gone. Health coverage, dental, vision is minimal. Hope you don't get sick. Cars are so basic not even a CD player and seats move manually.
- Where are the pay stubs? You have to dig to get access to it.
- No studies to leave behind? Why?
- They want success stories but nothing has been sold. They want cheerleading stories and people are making them up in detail just to give something to management.
WHAT DID I FORGET
Even if this was all completely true, then take the money while you find another job...but suppose maybe, just maybe it would only take a few changes and things would be much different.
1. By next season Oralair should be approved to be started all year round since data suggests in some areas multiple grass seasons. No more need for 4 month lead in changes things, period. How much...not sure, but definitely changes the conversation.
2. Agree that specialty pharmacy is a pain for sure, but prior authorizations are not an issue here specific to Oralair. Actually, the only criteria is a positive skin or blood test being attached by the physician. That's simple enough. Problem is the product need, not the prior auth.
3. Three years were published with the caveat there were no differences at year 4 and 5. The primary measures were met and clearly illustrated at 3 years. 4 and 5 years provided nothing meaningful positively or negatively to the data.
4. Definitely not vague about the lack of indication for age 5-9. Simply studies sufficiently powered to meet FDA requirements. When data was cut there wasn't statistically significant data in that age population due to lack of number of patients. FDA made the right decision here and Greer has reconciled the issues and it only when, not if that approval for 5-9 years of age will be on the table.
5. This is certainly a valid point with respect to shots, that said there is no denying that the combination of patients who refuse shots or stop coming back for shots is enough for Oralair to be doing much more business that the lackluster sales to date.
6. It's only for PCP use if reps go to PCP and sell it. And if it takes off at all in PCP, Allergist and ENT's will increase to stop losing these patients.
7. Savings card is $25 a month with above average access...don't really get the Zyrtec take it when you need it reference for patients with access.
8. Definitely possible the drug will not make money this season, but remember...OPEX is LOW! This 150 max person company. Any growth is better than last year, and Oralair will grow for sure. This is more about positioning Greer to have office access in the Allergy setting when they acquire a solid drug in the next year or so. Launch the salesforce...launch the drug when you get it (that's the idea...doesn't mean it's gonna happen...I get it)
9. Couldn't disagree more. Haven't had one word said to me about any of these things. Just get in the field and sell. Selling takes care of all these things.
10. I just don't see this...sort of. Yeah, receipts required for everything but can do unlimited breakfast, lunch, snacks, etc. Only req's are receipts and sign-in sheets, but thats the law...not a Greer rule.
11. I agree Marketing has way to many pieces, but that said...if you look half full, it's better than not having anything. Use what works and don't order what you don't need, but agree really could knock it down to Patient, Data, Dosing, Formulary, and that's about it...
12. I'm not sure it's that Leadership doesn't know, or if its just that because the company is so small, there's just an expectation that each section will just do there job, period. Sure, more synergy and collaboration would make things easier, but with the size of the company now...as a rep, not sure it impacts our day to day issues.
13. Can understand he commentary around benefits, especially since you don't really find out til after accepting the position. I do however find it funny when people talk about the FREE car they being given. I've never had company car I would ever consider purchasing for personal use. So, I guess if you've had nicer vehicles in the past then I can understand the disappointment, but I've alway had mid size sedans so doesn't bother me...plus I have personal vehicles anyway so maybe it doesn't bother me cause I only drive it for work.
14. Paystubs? All need is to register with mypaychex and you have access to your paystub. What's wrong with that? So it's a 3rd payroll versus internal paystub.
15. No studies to leave behind? Come on, really...have you met a customer yet who would give it a second look. Leave the monograph...it's the product relevant data soup to nuts.
16. Agree with the success stories, but thats pharma small and big. At the end of the day, stories are just that...the numbers will be what matters and nobody is counting number of stories regardless to what anybody thinks.
***Now trust me, I'm in agreement and totally understand all of your points, the purpose of my response was just to show you how easy it is or would be to turn things around if just a few small changes happened. Will they happen, maybe yes, maybe no...just keep the options open but I still think it's too early to jump ship.***
